Skip to content

Study on Clinical Effect and Correlation of Yiqi Kaimi Prescription in Treating Functional Constipation with Melanosis Coli

Study on Clinical Effect and Correlation of Yiqi Kaimi Prescription in Treating Functional Constipation with Melanosis Coli

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005980
Enrollment
Unknown
Registered
2022-05-06
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation with Melanosis Coli

Interventions

Polyethylene gilcol group:Polyethylene gilco 4000
Yiqi Kaimi Recipe group:Yiqi Kaimi Recipe

Sponsors

Longhua Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Functional constipation in accordance with Rome ? -Functional GI Disorders: Disorders of Gut-Brain Interaction; (2) Colonoscopy confirmed the diagnosis of melanosis coli; (3) 18-75 years old, male or female; (4) Meet the criteria of TCM syndrome waiting diagnosis of qi and Yin deficiency; (5) Patients are aware of this study and voluntarily agree to participate.

Exclusion criteria

Exclusion criteria: (1) complicated with cardiovascular, liver, kidney, hematopoietic and other serious diseases; (2) pregnant women, pregnant women and lactation patients; (3) Those who cannot express their chief complaints correctly, such as mental illness, neurosis or inability to cooperate; (4) Participated in other drug studies within 3 months before treatment.

Design outcomes

Primary

MeasureTime frame
Cleveland clinic score;

Secondary

MeasureTime frame
Rectal sensation;Patient Assessment of Constipation Quality of Life questionnaire;Anorectal manometry;Patient assessment of constipation symptom;Gastrointestinal electromyography;

Countries

China

Contacts

Public ContactWang Chen
wangchen_longhua@163.com+8618917763340

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026